This inventor holds 1 USPTO granted patent. Top assignee: Imclone Systems, Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Jurgen Hoppe: Innovator in Biopharmaceutical Production
Introduction
Jurgen Hoppe is a notable inventor based in Wurzburg, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the production of recombinant proteins. His work has implications for medical advancements and therapeutic applications.
Latest Patents
Jurgen Hoppe holds a patent for a PDGF-B fusion protein, vectors, and host cells for use in production. The present invention provides a method for the production of recombinant PDGF-B in prokaryotic cells. Additionally, it includes DNA constructs for fusion proteins that are useful in the production of biologically active products. This innovation highlights his expertise in genetic engineering and protein synthesis.
Career Highlights
Hoppe is associated with Imclone Systems, Inc., a company known for its focus on biopharmaceutical development. His role there has allowed him to work on cutting-edge technologies that advance the field of medicine. His contributions are vital in the ongoing quest for effective treatments and therapies.
Collaborations
Some of his notable coworkers include Charles T Tackney and Wolfram Eichner. Their collaborative efforts have likely enhanced the research and development processes within their projects.
Conclusion
Jurgen Hoppe's work exemplifies the innovative spirit in the biopharmaceutical industry. His patent for the PDGF-B fusion protein represents a significant advancement in the production of therapeutic proteins. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile